Gevo (NASDAQ:GEVO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

A number of other equities research analysts also recently issued reports on GEVO. HC Wainwright downgraded shares of Gevo from a “buy” rating to a “neutral” rating and set a $12.00 target price for the company. in a research report on Tuesday. ValuEngine downgraded shares of Gevo from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th.

Gevo (NASDAQ:GEVO) opened at $0.61 on Tuesday. Gevo has a 52 week low of $0.53 and a 52 week high of $4.98. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.54 and a quick ratio of 1.23. The company has a market cap of $13.30, a P/E ratio of -0.35 and a beta of 3.09.

Gevo (NASDAQ:GEVO) last posted its quarterly earnings data on Monday, November 6th. The energy company reported ($0.36) EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.05. Gevo had a negative net margin of 84.42% and a negative return on equity of 40.58%. The firm had revenue of $7.70 million during the quarter, compared to analyst estimates of $5.49 million. analysts forecast that Gevo will post -1.69 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Gevo stock. Vanguard Group Inc. increased its position in Gevo, Inc. (NASDAQ:GEVO) by 22.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 486,959 shares of the energy company’s stock after acquiring an additional 89,020 shares during the quarter. Vanguard Group Inc. owned about 3.23% of Gevo worth $336,000 at the end of the most recent quarter. 7.07% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/zacks-investment-research-lowers-gevo-gevo-to-hold/1802176.html.

About Gevo

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.